Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Chronic Orchialgia
NCT02058836Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in Chronic testicular pain (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Visual Analog Scale for Pain Score at 6 months, Quality of Life Questionnaire Score at 6 months and 1 more. Started Nov 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Chronic testicular pain
Beyond the preview
Go deeper on NCT02058836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058836.